StockNews.com Upgrades Maximus (NYSE:MMS) to “Buy”

Maximus (NYSE:MMS) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Wednesday.

Separately, Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd.

Maximus Price Performance

MMS stock opened at $75.99 on Wednesday. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The firm’s 50-day moving average price is $74.66 and its two-hundred day moving average price is $84.09. The stock has a market capitalization of $4.58 billion, a price-to-earnings ratio of 15.20 and a beta of 0.73. Maximus has a 12-month low of $69.72 and a 12-month high of $93.97.

Insiders Place Their Bets

In other news, Director Raymond B. Ruddy purchased 3,490 shares of Maximus stock in a transaction that occurred on Thursday, December 12th. The shares were bought at an average cost of $71.46 per share, with a total value of $249,395.40. Following the completion of the purchase, the director now directly owns 112,520 shares in the company, valued at approximately $8,040,679.20. This trade represents a 3.20 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Bruce Caswell acquired 3,500 shares of the stock in a transaction on Tuesday, December 17th. The shares were purchased at an average cost of $70.64 per share, with a total value of $247,240.00. Following the transaction, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 7,063 shares of company stock worth $502,017. 1.40% of the stock is currently owned by corporate insiders.

Institutional Trading of Maximus

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Assenagon Asset Management S.A. boosted its stake in Maximus by 277.0% during the third quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock worth $81,878,000 after acquiring an additional 645,760 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of Maximus by 942.9% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock valued at $27,707,000 after purchasing an additional 292,300 shares during the last quarter. Millennium Management LLC boosted its position in shares of Maximus by 150.4% in the 2nd quarter. Millennium Management LLC now owns 406,075 shares of the health services provider’s stock worth $34,801,000 after purchasing an additional 243,890 shares in the last quarter. Reinhart Partners LLC. grew its stake in shares of Maximus by 43.5% in the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider’s stock worth $41,143,000 after buying an additional 167,019 shares during the last quarter. Finally, Sio Capital Management LLC bought a new position in Maximus during the 3rd quarter valued at approximately $14,453,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.